Testing effectiveness (Phase 2)Study completedNCT02423122
What this trial is testing
A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)
Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
EIP Pharma Inc 16